SGP SpyGlass Pharma, Inc.
$30.90▲ +3.31%
Healthcare
Other
After hours
$30.90▲ +0.00%
Oct 27, 4:00 PM ET
Volume 69.3K
Avg Volume (10D) 73.7K
Key Metrics & Fundamentals
Market Cap
$1.03B
P/E Ratio
–
Div Yield
0.00%
52W Range
17.06 - 32.44
% vs 50 MA
15.04%
% vs 200 MA
–%
RSI-14
70.7
MACD Histogram
+0.7200
Beta (1Y vs SPY)
1.46
Free Cash Flow
-$16.77M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$21.63M
COGS
–
Operating Exp
$21.97M
Operating Income
-$21.97M
EBIT
-$21.97M
Pretax Income
-$19.86M
Net Income
-$19.86M
EPS (Diluted)
-0.59
Price & Volume History
Loading chart…
Recent News
SpyGlass Pharma Reports Trial of Eye Implant Lowers Pressure by 37%
MT Newswires · Oct 19, 2026 9:21 AM ET
SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System
GlobeNewswire · Oct 19, 2026 8:00 AM ET
SpyGlass Pharma Acquires Advanced Vision Science for $13 Million
MT Newswires · Oct 1, 2026 8:54 AM ET
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability
GlobeNewswire · Oct 1, 2026 8:00 AM ET
SpyGlass Pharma to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 8:00 AM ET
SpyGlass Pharma Celebrates Grand Opening of New Irvine Headquarters, Positioning Itself for First Product Launch and Custom R&D Space
PR Newswire · Aug 27, 2026 4:40 PM ET
Raymond James Initiates SpyGlass Pharma at Outperform, With $39 Price Target
MT Newswires · Aug 14, 2026 7:14 AM ET
SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
GlobeNewswire · Aug 6, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See SGP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.